Please login to the form below

Not currently logged in
Email:
Password:

Hill & Knowlton appoints Daniel McIntyre

Hill & Knowlton has appointed Daniel McIntyre as worldwide head of healthcare to drive the company's growth strategy in this sector

Hill & Knowlton (H&K) has appointed Daniel McIntyre as worldwide head of healthcare. McIntyre will drive the company's growth strategy in healthcare, integrating its assets to address the complex communications needs of client organisations active throughout the sector.

McIntyre joins H&K from integrated marketing communications consultancy Global Prairie where he was partner. His experience includes product marketing, corporate reputation, issues management, international public affairs and public policy. 

He has more than 30 years of working in the industry for companies including Fleishman Hillard, Wyeth, MeadWestvaco, Pharmacia, Bayer, American Home Products and Hoffman La Roche.

Based in New York, McIntyre will report to Paul Taafe, chairman and global CEO. Taafe said: "Dan's experience is key as H&K responds to the needs of our growing healthcare roster. Our clients face some of the toughest challenges globally such as litigation, regulatory oversight, risk communications, reimbursement and market access. These require an increasingly holisitic view of the healthcare world."

McIntyre said: "As opportunities expand for healthcare organisations worldwide so do the complexities of societal expectations and obligations inherent in the industry. No firm is better positioned than H&K to advise and counsel in this healthcare landscape."

1st June 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Hive

We're a healthcare communications agency that does things differently. We put patients at the heart of everything we do, while...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics